CCL2 and ductal breast carcinoma in situ: DCIS.com cells were treated with CCL2 or HGF alone or co-stimulated with CCL2 and HGF for 1, 4 and 8 hours and subject to metabolomics profiling by liquid chromatography/mass spectrometry (LC-MS).